Incannex Healthcare (IXHL) EPS (Weighted Average and Diluted) (2022 - 2026)

Incannex Healthcare has disclosed EPS (Weighted Average and Diluted) across 5 years of filings, most recently posting -$0.35 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.35, up 94.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.65 (up 428.47% YoY), and the FY2025 annual result was -$1.35, down 17.39% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$0.35 for Q1 2026 at Incannex Healthcare, down from -$0.02 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $24.04 in Q2 2025 to a low of -$6.19 in Q1 2025.
• The 5-year median for EPS (Weighted Average and Diluted) is -$0.28 (2024), against an average of $1.07.
• Peak annual rise in EPS (Weighted Average and Diluted) reached 6264.1% in 2025, while the deepest fall reached 1528.95% in 2025.
• Incannex Healthcare's EPS (Weighted Average and Diluted) stood at -$0.2 in 2022, then plunged by 68.52% to -$0.33 in 2023, then changed by 0.0% to -$0.33 in 2024, then jumped by 93.94% to -$0.02 in 2025, then sank by 1650.0% to -$0.35 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.35 (Q1 2026), -$0.02 (Q4 2025), and -$0.02 (Q3 2025), per Business Quant data.